These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 9275627)
41. Effect of polydatin on phospholipase A2 in lung tissues in rats with endotoxic shock. Shu SY; Wang XY; Ling ZY; Lu ZY Chin J Traumatol; 2004 Aug; 7(4):239-43. PubMed ID: 15294104 [TBL] [Abstract][Full Text] [Related]
42. Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endotoxic shock. Neyrinck AM; Alexiou H; Delzenne NM J Nutr; 2004 May; 134(5):1124-9. PubMed ID: 15113957 [TBL] [Abstract][Full Text] [Related]
43. A radionuclide model for studying changes in the regional blood volumes during early endotoxic shock: an experimental model. Christenson JT; Al-Sarraf AA; Kuikka J; Owunwanne A Am J Physiol Imaging; 1986; 1(2):77-82. PubMed ID: 2837257 [TBL] [Abstract][Full Text] [Related]
44. Differential protective activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor. Schade UF; Engel R; Jakobs D Int J Immunopharmacol; 1991; 13(5):565-71. PubMed ID: 1783470 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms of endotoxin shock in rats and the anti-endotoxic effect of glucocorticoids and endotoxin-conditioning. Fukuda T; Hata N Jpn J Physiol; 1969 Aug; 19(4):509-20. PubMed ID: 5307437 [No Abstract] [Full Text] [Related]
47. Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2 through inhibiting production and action of TNF. Watanabe S; Mukaida N; Ikeda N; Akiyama M; Harada A; Nakanishi I; Nariuchi H; Watanabe Y; Matsushima K Int Immunol; 1995 Jul; 7(7):1037-46. PubMed ID: 8527401 [TBL] [Abstract][Full Text] [Related]
48. Centrally acting endogenous hypotensive substances in rats subjected to endotoxic shock. Xu T; Wang T; Han JS Life Sci; 1992; 51(23):1817-21. PubMed ID: 1435090 [TBL] [Abstract][Full Text] [Related]
57. A STUDY OF EXPERIMENTAL AND CLINICAL SHOCK WITH SPECIAL REFERENCE TO ITS TREATMENT BY THE INTRAVENOUS INJECTION OF PRESERVED PLASMA. Mahoney EB Ann Surg; 1938 Aug; 108(2):178-93. PubMed ID: 17857225 [No Abstract] [Full Text] [Related]
58. I. Studies in Blood-pressure Before, During, and After Operations with Reference to the Early Recognition, Prevention, and Treatment of Shock. Bloodgood JC Ann Surg; 1913 Dec; 58(6):721-39. PubMed ID: 17863103 [No Abstract] [Full Text] [Related]
59. [Prevention of endotoxic shock in rats with hepatic stimulating substance]. Zeng W; Ren H; Zhang D Zhonghua Nei Ke Za Zhi; 1996 Feb; 35(2):99-102. PubMed ID: 9275627 [TBL] [Abstract][Full Text] [Related]
60. [The effect of transmembrane- and secreted-tumor necrosis factor-alpha on shock liver]. Yin B; Li Z; Yu S; Jiang X; Feng W; Xu Y Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):534-7. PubMed ID: 12622907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]